CISPLATINUM AS A SINGLE AGENT VERSUS CISPLATINUM IN 2 DRUG-COMBINATION IN ADVANCED AND RECURRENT HEAD AND NECK-CANCER

被引：0
|
作者：
CAMPBELL, JB
MORTON, RP
DORMAN, EB
RUGMAN, F
WILSON, JA
STELL, PM
机构：
来源：
CLINICAL OTOLARYNGOLOGY | 1987年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [41] A PHASE-II STUDY OF PIRITREXIM IN COMBINATION WITH METHOTREXATE IN RECURRENT AND METASTATIC HEAD AND NECK-CANCER
    VOKES, EE
    DIMERY, IW
    JACOBS, CD
    KARP, D
    MOLINA, A
    COLLIER, MA
    EBLE, ML
    CLENDENINN, NJ
    CANCER, 1991, 67 (09) : 2253 - 2257
  • [42] SINGLE FRACTION PER DAY VERSUS 2 FRACTIONS PER DAY VERSUS RADIOCHEMOTHERAPY IN THE TREATMENT OF HEAD AND NECK-CANCER
    SANCHIZ, F
    MILLA, A
    TORNER, J
    BONET, F
    ARTOLA, N
    CARRENO, L
    MOYA, LM
    RIERA, D
    RIPOL, S
    CIRERA, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (06): : 1347 - 1350
  • [43] Single agent versus combination of drugs in advanced pancreatic cancer
    Louvet, C.
    EJC SUPPLEMENTS, 2007, 5 (04): : 42 - 42
  • [44] CORRELATION BETWEEN RESPONSE TO CISPLATINUM-COMBINATION CHEMOTHERAPY AND SUBSEQUENT RADIOTHERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED SQUAMOUS-CELL CANCERS OF THE HEAD AND NECK
    ENSLEY, JF
    JACOBS, JR
    WEAVER, A
    KINZIE, J
    CRISSMAN, J
    KISH, JA
    CUMMINGS, G
    ALSARRAF, M
    CANCER, 1984, 54 (05) : 811 - 814
  • [45] Phase 2b Randomized Trial Comparing Concurrent Chemoradiation With Weekly Versus 3 Weekly Cisplatinum in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Kumar, R. R.
    Haridas, G.
    Kainickal, C. T.
    Sudha, A. S.
    Rafi, M.
    Raghavan, R.
    Ramadas, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S566 - S566
  • [46] 24-HOUR COMBINATION CHEMOTHERAPY WITHOUT CISPLATIN IN PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK-CANCER
    HILL, BT
    SHAW, HJ
    DALLEY, VM
    PRICE, LA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (04): : 335 - 340
  • [47] A retrospective study of induction chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil followed by concurrent radiotherapy with cetuximab in locally advanced head and neck cancer
    Kim, Brian
    Dillman, Robert O.
    Chen, Peter
    Hafer, Russell
    Cox, Craig
    Barth, Neil
    Carroll, Matthew
    VanderMolen, Louis
    Nguyen, Minh
    Huang, JinChu
    Minion, Annamarie
    Plunkett, Marianne
    Mackintosh, Ralph
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (01) : 93 - 97
  • [48] Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer - A single institution experience of 361 patients
    Pai, VR
    Mazumdar, AT
    Deshmukh, CD
    Bakshi, AV
    Parikh, DM
    Parikh, PM
    Mistry, RC
    Pathak, KA
    D'Cruz, AK
    MEDICAL ONCOLOGY, 2004, 21 (04) : 305 - 308
  • [49] RANDOMIZED NEOADJUVANT STUDY OF 5-FLUOROURACIL (FU) AND CISPLATINUM (DDP) FOR PATIENTS (PTS) WITH ADVANCED RESECTABLE HEAD AND NECK SQUAMOUS CANCER (ARHNSC)
    HAAS, C
    ANDERSON, T
    BYHARDT, R
    COX, J
    DUNCAVAGE, J
    GROSSMAN, T
    HAAS, J
    LIBNOCH, J
    MALIN, T
    RITCH, P
    TOOHILL, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 185 - 185
  • [50] CIS-PLATINUM VERSUS CIS-PLATINUM + METHOTREXATE FOR THE TREATMENT OF RECURRENT HEAD AND NECK-CANCER
    JACOBS, C
    HEAD & NECK SURGERY, 1981, 3 (03): : 256 - 257
12345